Your search for

82 results were returned

  1. Twobirds news
    08 June 2020
    Bird & Bird expands its Intellectual Property practice with the arrival of patent litigation specialist José Miguel Lissén Arbeloa in Madrid
    www.twobirds.com/en/news/press-releases/2020/bird-and-bird-expands-its-intellectual-property-practice

    International law firm Bird & Bird today expands its Intellectual Property practice with the appointment of patent litigation specialist José Miguel Lissén Arbeloa as a partner in Madrid.

  2. Legal news
    09 April 2020
    China Imposes New Export Restrictions for COVID-19 Medical Products
    www.twobirds.com/en/news/articles/2020/china/china-imposes-new-export-restrictions-for-covid-19-medical-products

    On 31 March 2020, the “Ministry of Commerce, General Administration of Customs and the National Medical Product Administration (NMPA) issued Notice No. 5 of 2020 – Notice on the Orderly Conducting of Medical Materials ...

  3. Legal news
    16 September 2020
    NMPA and CNIPA issue Draft Patent Linkage Measures in China
    www.twobirds.com/en/news/articles/2020/china/nmpa-and-cnipa-issue-draft-patent-linkage-measures-in-china

    On 11 September 2020, the National Medical Products Administration ("NMPA") and the China National Intellectual Property Administration ("CNIPA") issued the draft "Implementing Measures for Drug Patent Dispute Early ...

  4. Legal news
    31 December 2020
    Medical Device UDI System Goes Live in China on 1 January 2021
    www.twobirds.com/en/news/articles/2020/china/medical-device-udi-system-goes-live-in-china-on-1-january-2021

    Those in the medical device industry will be familiar with the Unique Device Identification (“UDI”) system for medical devices. While it has been a global discussion piece for many years, the timeline for implementation ...

  5. Legal news
    04 December 2020
    Supplemental Protection Period for pharmaceutical patents in China - Update
    www.twobirds.com/en/news/articles/2020/china/supplemental-protection-period-for-pharmaceutical-patents-in-china---update

    On 27 November 2020, the China National Intellectual Property Administration (“CNIPA”) issued the draft Implementing Regulations of the PRC Patent Law (“Draft Amendments for Implementing Regulations”) for public ...

  6. Legal news
    03 August 2020
    China Updates Drug Registration Rules and the Measures for Monitoring Drug Production – Part 2
    www.twobirds.com/en/news/articles/2020/china/china-updates-drug-registration-rules-and-the-measures-for-monitoring-drug

    The restating of the expedited review pathways, and the recently published work procedures, appear to be a step toward improving a process that has seemingly changed numerous times over the years.

  7. Legal news
    04 November 2020
    Chinese patent linkage system - the Chinese Supreme Court issues Draft Judicial Interpretations
    www.twobirds.com/en/news/articles/2020/china/chinese-patent-linkage-system---the-chinese-supreme-court-issues-draft-judicial-interpretations

    As the patent linkage provisions are new for China, the Draft Judicial Interpretations provide some guidance on how the system will be implemented in practice. The Draft Judicial Interpretations are open for public ...

  8. Legal news
    25 February 2020
    Surgical face masks – filtering out counterfeit copies
    www.twobirds.com/en/news/articles/2020/global/surgical-face-masks-filtering-out-counterfeit-copies

    This article discusses the key IP and regulatory issues relating to surgical masks and penalties for the production of counterfeit products.

  9. Legal news
    09 April 2020
    COVID-19 (Temporary Measures) Act 2020: Legal circuit breaker
    www.twobirds.com/en/news/articles/2020/singapore/covid19-temporary-measures-act-2020-legal-circuit-breaker

    In our previous article (Temporary Relief for Inability to Perform Contractual Obligations due to the COVID-19 Situation in Singapore), we had highlighted that the Ministry of Law had on 1 April 2020 announced its ...

  10. Legal news
    23 March 2020
    Therapeutic product registration could be jeopardised by omitting to disclose a pertinent patent, regardless of whether the omission was wilful
    www.twobirds.com/en/news/articles/2020/singapore/ip-update-therapeutic-product-registration

    Pursuant to the Health Products (Therapeutic Products) Regulations ("HPR"), applicants for registration of a therapeutic product with the Health Sciences Authority ("HSA") in Singapore must declare whether "a patent is ...